Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 11 de 11
Filtrar
1.
Coron Artery Dis ; 20(2): 100-5, 2009 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-19293667

RESUMEN

OBJECTIVE: To delineate the effects of extracorporeal bypass on biomarkers of hemostasis, fibrinolysis, and inflammation and clinical sequelae. METHODS: Patients were assigned prospectively and randomly to either on-pump (n=41) or off-pump (n=51) coronary bypass surgery. The concentrations of C-reactive protein, fibrinogen, D-dimer, and plasminogen activator inhibitor type-1 in blood were quantified before and after (1 and 24 h) surgery. Similar surgical and anesthetic procedures were used for both groups. Clinical events were assessed during initial hospitalization and at the end of 1 year. RESULTS: The concentrations of plasminogen activator inhibitor type-1 and D-dimer were greater compared with preoperative values 1 and 24 h after surgery in both groups, but their concentrations increased to a greater extent 24 h after surgery in the on-pump group (P<0.01). The concentration of C-reactive protein did not change appreciably immediately after surgery in either group but increased in a parallel manner 24 h after either on-pump or off-pump surgery (P<0.01). Bypass surgery in the on-pump group was associated with greater blood loss during surgery and more bleeding after surgery (P< or =0.01). The incidence of all other complications was similar in the two groups. CONCLUSION: On-pump surgery was associated with biochemical evidence of a prothrombotic state early after surgery but no greater incidence of thrombotic events was observed. The prothrombotic state might be a consequence of extracorporeal bypass, compensation in response to more bleeding, or both in patients undergoing on-pump surgery.


Asunto(s)
Pérdida de Sangre Quirúrgica/prevención & control , Puente Cardiopulmonar/efectos adversos , Puente de Arteria Coronaria Off-Pump/efectos adversos , Puente de Arteria Coronaria/efectos adversos , Enfermedad de la Arteria Coronaria/cirugía , Hemostasis , Hemorragia Posoperatoria/prevención & control , Trombosis/sangre , Anciano , Biomarcadores/sangre , Proteína C-Reactiva/metabolismo , Enfermedad de la Arteria Coronaria/sangre , Femenino , Productos de Degradación de Fibrina-Fibrinógeno/metabolismo , Fibrinógeno/metabolismo , Fibrinólisis , Humanos , Mediadores de Inflamación/sangre , Masculino , Persona de Mediana Edad , Inhibidor 1 de Activador Plasminogénico/sangre , Hemorragia Posoperatoria/sangre , Hemorragia Posoperatoria/etiología , Estudios Prospectivos , Trombosis/etiología , Factores de Tiempo , Resultado del Tratamiento
2.
Buenos Aires; Kargieman; 1994. 309 p. (112933).
Monografía | BINACIS | ID: bin-112933
3.
Buenos Aires; Kargieman; 1994. 309 p. (112423).
Monografía | BINACIS | ID: bin-112423
4.
Buenos Aires; Kargieman; 1994. 309 p. (112422).
Monografía | BINACIS | ID: bin-112422
5.
7.
West Indian med. j ; 35(3): 200-2, Sept. 1986.
Artículo en Inglés | MedCarib | ID: med-11575

RESUMEN

A few scattered reports have appeared in the literature in the last few years suggesting that focal and segmental glomerulosclerosis may be associated with the acquired immunodeficiency syndrome, leading to rapid deterioration of renal function with uraemia. This communication describes the first such case seen at Port-of-Spain General Hospital, Trinidad (AU)


Asunto(s)
Adulto , Humanos , Masculino , Síndrome de Inmunodeficiencia Adquirida/complicaciones , Glomerulonefritis/etiología , Glomeruloesclerosis Focal y Segmentaria/diagnóstico , Trinidad y Tobago
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA